Citalopram Hydrobromide
Who holds supplier records for Citalopram Hydrobromide? 17 organisations hold a current record for Citalopram Hydrobromide: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability (12 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (13), China (1) and Denmark (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Citalopram Hydrobromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/citalopram-hydrobromide
Reading the evidence
- 17 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
13 of the 15 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (17)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Citalopram Hydrobromide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 16850, 19588 · latest filing Jun 2006
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 17979, 25088 · latest filing Jun 2011
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 15587, 20013 · latest filing Nov 2006
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 15813, 16553, 38100 · latest filing Mar 2023
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 21165 · latest filing Dec 2007
- Natco PharmaIndiaCEP Company GMP cert on recordActive DMF 17185 · latest filing Feb 2004
- VIRUPAKSHA ORGANICS LTDIndiaCEPActive DMF 36925 · latest filing May 2023
- WUXI JIDA PHARMACEUTICAL CO LTDCEPActive DMF 23979 · latest filing Jul 2010
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 20586 · latest filing Jun 2007
- ARCH PHARMALABS LTDIndiaActive DMF 16045, 23566 · latest filing Mar 2010
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 22658 · latest filing Mar 2009
- H LUNDBECK ASCEPActive DMF 12384 · latest filing Feb 1997
- RAKS PHARMA PVT LTDIndiaActive DMF 25065 · latest filing Jun 2011
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 17074 · latest filing Jan 2004
- DenmarkCEP Company GMP cert on record
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordInactive DMF 24121 · latest filing Dec 2010
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (12)
Certificates of Suitability on the EDQM register for Citalopram Hydrobromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2012-120 - Rev 06 Citalopram hydrobromide, CTP Process | Aug 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2021-462 - Rev 02 Citalopram hydrobromide, Process II | Jun 2026 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2009-012 - Rev 03 Citalopram hydrobromide | May 2026 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2010-037 - Rev 02 Citalopram hydrobromide, Micronised and non-micronised | Apr 2026 | Inspected May 2026 Italy |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2010-379 - Rev 03 Citalopram hydrobromide, DGR process | Mar 2026 | — |
| VIRUPAKSHA ORGANICS LIMITED Hyderabad | IN | CEP 2021-437 - Rev 01 Citalopram hydrobromide | Oct 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2009-043 - Rev 03 Citalopram hydrobromide | Jul 2025 | — |
| SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad | IN | R1-CEP 2010-228 - Rev 02 Citalopram hydrobromide | Oct 2022 | — |
| WUXI JIDA PHARMACEUTICAL CO., LTD. Jiangyin | CN | R1-CEP 2011-214 - Rev 00 Citalopram hydrobromide | Sept 2017 | — |
| NATCO PHARMA LIMITED Hyderabad | IN | R1-CEP 2009-390 - Rev 01 Citalopram hydrobromide | Feb 2017 | — |
| H. Lundbeck A/S Valby | DK | R1-CEP 2010-222 - Rev 00 Citalopram hydrobromide | Jan 2017 | — |
| IPCA Laboratories Limited Mumbai | IN | R1-CEP 2010-296 - Rev 00 Citalopram hydrobromide | Dec 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Citalopram Hydrobromide are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- JIANGSU JIWA RINTECH PHARMACEUTICAL CO LTDInactive DMF 20094 · filed Dec 2006
- ESTEVE QUIMICA SAInactive DMF 17511 · filed Jul 2004
- RANBAXY LABORATORIES LTDInactive DMF 17334 · filed Apr 2004
- HEUMANN PHARMA GMBHInactive DMF 17104 · filed Jan 2004
- India · Inactive DMF 16788, 16979 · filed Nov 2003
- MYLAN LABORATORIES LTDInactive DMF 16961 · filed Nov 2003
- Finland · Inactive DMF 16700 · filed Jul 2003
- Japan · Inactive DMF 15836 · filed Jan 2002
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Citalopram Hydrobromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200781).
Chemical identity
- IUPAC name
- 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide
- Canonical SMILES
- CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.Br
- InChIKey
- WIHMBLDNRMIGDW-UHFFFAOYSA-N
- Synonyms
- Celexa, Cipramil, Citalopram (as hydrobromide), Citalopram hbr, Citalopram hydrobromide, LU 10-171-B, LU-10-171-B, NSC-758684, Paxoran, Seropram, Elopram, Perrigo citalopram
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin Reuptake Inhibitor
- Mechanism of action
- Serotonin Uptake Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Citalopram Hydrobromide?
17 organisations hold an active US FDA Type II Drug Master File or a CEP for Citalopram Hydrobromide: APITORIA PHARMA PRIVATE LTD (India), Hetero Drugs Limited (India), JUBILANT BIOSYS LTD (India), Cipla Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Natco Pharma (India), VIRUPAKSHA ORGANICS LTD (India) and WUXI JIDA PHARMACEUTICAL CO LTD, and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Citalopram Hydrobromide Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 16850, 19588), Hetero Drugs Limited (DMF 17979, 25088), JUBILANT BIOSYS LTD (DMF 15587, 20013), Cipla Limited (DMF 15813, 16553), MATRIX PHARMACORP PRIVATE LTD (DMF 21165), Natco Pharma (DMF 17185), VIRUPAKSHA ORGANICS LTD (DMF 36925) and WUXI JIDA PHARMACEUTICAL CO LTD (DMF 23979) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Citalopram Hydrobromide records mean?
8 organisations have only inactive Type II DMFs for Citalopram Hydrobromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Citalopram Hydrobromide have a European Certificate of Suitability?
Yes. 13 organisations hold a valid CEP for Citalopram Hydrobromide on the EDQM register, including HETERO DRUGS LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), CIPLA LIMITED Mumbai (IN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), JUBILANT BIOSYS LIMITED Mysuru (IN) and VIRUPAKSHA ORGANICS LIMITED Hyderabad (IN) and 6 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Citalopram Hydrobromide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Citalopram Hydrobromide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.